{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T20:33:33Z","timestamp":1762202013490,"version":"build-2065373602"},"reference-count":31,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["aspenjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Parenter Enteral Nutr"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with type 2 intestinal failure (IF) are metabolically unstable and prone to electrolyte derangements. Nevertheless, the data on the prevalence of hypercalcemia in these patients are lacking to date. The aim of this study was therefore to evaluate the prevalence and causes of hypercalcemia in patients with type 2 IF during their first admission to a dedicated IF unit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a cohort study of patients with a new diagnosis of type 2 IF admitted to a national UK IF Reference Centre between July 1, 2018, and April 31, 2023. Patients with identified hypercalcemia were followed up from their admission until parenteral support cessation or end of the follow\u2010up on December 31, 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, there were 265 patients included in the analysis. In total, 26\/265 (9.8%) patients were diagnosed with hypercalcemia during the admission. In most patients, the cause of hypercalcemia was multifactorial with immobilization, dehydration, and presence of calcium in parenteral support being the most common factors. In all cases, hypercalcemia was transient and resolved by the end of patient admission with continuous optimization of hydration, reduction in supplemented calcium, and\/or improved patient mobility. Notably, 11\/26 (45.8%) patients with transient inpatient hypercalcemia remained on calcium\u2010free parenteral support after hospital discharge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hypercalcemia is present in almost 10% of all admissions with type 2 IF and is multifactorial in origin. Care should be undertaken to optimize patient hydration, parenteral support prescription, and mobilization in the acute hospital setting, with ongoing assessment of calcium requirements following discharge.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jpen.70005","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T08:15:42Z","timestamp":1756109742000},"page":"1021-1027","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypercalcemia in patients with type 2 intestinal failure receiving parenteral support: A descriptive cohort study"],"prefix":"10.1002","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3448-9476","authenticated-orcid":false,"given":"Maja","family":"Kopczynska","sequence":"first","affiliation":[{"name":"Intestinal Failure Unit Salford Royal NHS Foundation Trust Salford UK"},{"name":"School of Health Sciences University of Manchester Manchester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thaksala","family":"Uduvawidana","sequence":"additional","affiliation":[{"name":"Intestinal Failure Unit Salford Royal NHS Foundation Trust Salford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Harrison","sequence":"additional","affiliation":[{"name":"Intestinal Failure Unit Salford Royal NHS Foundation Trust Salford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorrel","family":"Burden","sequence":"additional","affiliation":[{"name":"Intestinal Failure Unit Salford Royal NHS Foundation Trust Salford UK"},{"name":"School of Health Sciences University of Manchester Manchester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon L.","family":"Carlson","sequence":"additional","affiliation":[{"name":"Intestinal Failure Unit Salford Royal NHS Foundation Trust Salford UK"},{"name":"School of Health Sciences University of Manchester Manchester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Lal","sequence":"additional","affiliation":[{"name":"Intestinal Failure Unit Salford Royal NHS Foundation Trust Salford UK"},{"name":"School of Health Sciences University of Manchester Manchester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"volume-title":"StatPearls","year":"2025","author":"Sadiq NM","key":"e_1_2_8_2_1"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15402"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2018.05.004"},{"key":"e_1_2_8_5_1","unstructured":"National Institute for Health and Care Excellence. NICE clinical knowledge summaries: hypercalcaemia. Accessed January 12 2025.https:\/\/cks.nice.org.uk\/topics\/hypercalcaemia\/"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab504"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2004.10.006"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(76)90052-8"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2014.08.017"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-002173"},{"issue":"10","key":"e_1_2_8_11_1","first-page":"600","article-title":"Managing the adult patient with short bowel syndrome","volume":"13","author":"Parrish CR","year":"2017","journal-title":"Gastroenterol Hepatol (NY)"},{"issue":"6","key":"e_1_2_8_12_1","first-page":"13","article-title":"Fluid and electrolyte management in parenteral nutrition","volume":"27","author":"Kingly J","year":"2005","journal-title":"Support Line"},{"key":"e_1_2_8_13_1","unstructured":"National Institute for Health and Care Excellence. Chronic kidney disease: assessment and management. NICE guideline NG203. Published August 25 2021. Updated November 24 2021. Accessed March 15 2025.https:\/\/www.nice.org.uk\/guidance\/ng203"},{"issue":"48","key":"e_1_2_8_14_1","first-page":"49","article-title":"Pressure sores: a risk assessment card","volume":"81","author":"Waterlow J","year":"1985","journal-title":"Nurs Times"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-92-3-343"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/35.5.993"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(80)90384-4"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/0115426505020005559"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.47.SupplMarch_S137"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1995.01430040104024"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000576192.80200.eb"},{"issue":"3","key":"e_1_2_8_22_1","first-page":"e371","article-title":"Hypercalcemia and hypophosphatemia among preterm infants receiving aggressive parenteral nutrition","volume":"116","author":"Brener Dik PH","year":"2018","journal-title":"Arch Argent Pediatr"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000000251"},{"issue":"1","key":"e_1_2_8_24_1","first-page":"46","article-title":"Immobilization induced hypercalcemia","volume":"13","author":"Cano\u2010Torres EA","year":"2016","journal-title":"Clin Cases Miner Bone Metab"},{"key":"e_1_2_8_25_1","first-page":"A186","article-title":"Dedicated physiotherapy in intestinal failure improves patient outcomes and quality of life","volume":"70","author":"Swinn J","year":"2021","journal-title":"Gut"},{"key":"e_1_2_8_26_1","unstructured":"American Society for Parenteral and Enteral Nutrition. Appropriate dosing for parenteral nutrition: ASPEN recommendations.https:\/\/www.nutritioncare.org\/pnresources\/"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2020.1851859"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/08860220500531005"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/jpen.2663"},{"key":"e_1_2_8_30_1","unstructured":"AllanP NightingaleJ JavaidK;BIFA Committee. BIFA guidelines for the prevention and treatment of metabolic bone disease in patients with chronic intestinal failure. British Association for Parenteral and Enteral Nutrition. Published February2024.https:\/\/www.bapen.org.uk\/pdfs\/bifa\/guidelines-for-metabolic-bone-disease-in-if.pdf"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2023.07.019"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2016.04.009"}],"container-title":["Journal of Parenteral and Enteral Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aspenjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jpen.70005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T20:19:37Z","timestamp":1762201177000},"score":1,"resource":{"primary":{"URL":"https:\/\/aspenjournals.onlinelibrary.wiley.com\/doi\/10.1002\/jpen.70005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1002\/jpen.70005"],"URL":"https:\/\/doi.org\/10.1002\/jpen.70005","archive":["Portico"],"relation":{},"ISSN":["0148-6071","1941-2444"],"issn-type":[{"type":"print","value":"0148-6071"},{"type":"electronic","value":"1941-2444"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"2025-04-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}